Completed OBSERVATIONAL NCT02946840

The Use of a New Core Needle in the Endoscopic Ultrasound Assisted Tissue Sampling for Pancreatic Solid Masses

Sponsor: Azienda Ospedaliera Universitaria Integrata Verona

Interventions FNA with 25 G Beacon needle

Updated 8 times since 2017 Last updated: Aug 7, 2018 Started: Aug 31, 2016 Primary completion: May 31, 2017 Completion: May 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Pancreatic Masses and is currently completed. Azienda Ospedaliera Universitaria Integrata Verona leads this study, which shows 8 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Sep 2022 — Jul 2024 [monthly]

Completed
Jan 2021 — Sep 2022 [monthly]

Completed
Sep 2018 — Jan 2021 [monthly]

Completed

Status: Recruiting → Completed

▶ Show 3 earlier versions

Jun 2018 — Sep 2018 [monthly]

Recruiting
Apr 2018 — Jun 2018 [monthly]

Recruiting

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Recruiting NA

First recorded

Aug 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Azienda Ospedaliera Universitaria Integrata Verona
Azienda Unità Sanitaria Locale di Imola
Catholic University of the Sacred Heart
Istituto Clinico Humanitas
Maggiore Bellaria Hospital, Bologna
The Mediterranean Institute for Transplantation and Advanced Specialized Therapies

Data source: Istituto Clinico Humanitas

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rozzano, Italy